Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05617898 · ClinicalTrials.gov registry record · NA
Determining the Role of Social Reward Learning in Social Anhedonia
A NA study of Psychosis, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 152
- Enrollment target
- 2
- Study locations
NCT05617898 is a NA study of Psychosis that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 152 participants, below the 174-participant average among 35 other Psychosis trials with a reported enrollment target (13% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05617898, a NA study of Psychosis, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 152 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be randomized 1:1 to motivational interviewing or a time- and format-matched control probe. At pre- and post-probe, participants will perform two social reward learning tasks in the scanner. With this design feature, we will examine the relationship between sensitivity to social reward and reduced subjective experience of social pleasure at both the behavioral and neural levels.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing
- BEHAVIORAL Nutrition Didactic Training
Study Locations (2)
Alabama
- University of Alabama at Birmingham - Birmingham
California
- University of California Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 152 participants |
| Start Date | 2023-06-14 |
| Est. Completion | 2027-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05617898
The ClinicalTrials.gov registry entry for NCT05617898 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 152 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 174-participant average among 35 other Psychosis trials with a reported enrollment target (13% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Psychosis appearing as the primary indexed condition, and to 2 interventions - of which Motivational Interviewing is the first listed.
NCT05617898 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, California.
Frequently Asked Questions
What is clinical trial NCT05617898 about?
NCT05617898 is a clinical study titled "Determining the Role of Social Reward Learning in Social Anhedonia". This is a clinical trial study that aims to evaluate the specificity of the relationship between reduced sensitivity to social reward and social anhedonia at both behavioral and neural levels. Individuals who recently experienced their first-episode psychosis will be recruited. Participants will be ...
What is the current status of trial NCT05617898?
This trial is currently recruiting. It is a NA study. The enrollment target is 152 participants. The study started on 2023-06-14. Estimated completion is 2027-11.
What conditions does trial NCT05617898 study?
This clinical trial studies the following conditions: Psychosis.
What interventions are being tested in trial NCT05617898?
The interventions under investigation include: Motivational Interviewing (BEHAVIORAL), Nutrition Didactic Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05617898?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05617898 being conducted?
This trial has 2 study locations across Alabama, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Psychosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
RECRUITING · NA
-
Cerebellar Modulation of Cognition in Psychosis
RECRUITING · NA
-
Precision Brain Stimulation to Reduce Cannabis Craving in Schizophrenia
RECRUITING · NA
-
Acute Psychiatric Care at Home for Lower-risk Patients With Acute Psychiatric Illness Who Require Inpatient Care
RECRUITING · NA
-
Targeting Emotion Dysregulation to Reduce Suicide in People With Psychosis
RECRUITING · NA
-
Normobaric Oxygen Therapy for Individuals With First-Episode Psychosis
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.